PL2057153T3 - POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY - Google Patents
POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINYInfo
- Publication number
- PL2057153T3 PL2057153T3 PL07764480T PL07764480T PL2057153T3 PL 2057153 T3 PL2057153 T3 PL 2057153T3 PL 07764480 T PL07764480 T PL 07764480T PL 07764480 T PL07764480 T PL 07764480T PL 2057153 T3 PL2057153 T3 PL 2057153T3
- Authority
- PL
- Poland
- Prior art keywords
- dialkoxyphtalazine
- dialkoxyisoquinoline
- dialkoxyquinazoline
- piperazin
- aryl
- Prior art date
Links
- 150000005513 6,7-dialkoxyisoquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81985506P | 2006-07-10 | 2006-07-10 | |
| DKPA200600951 | 2006-07-10 | ||
| EP07764480A EP2057153B1 (en) | 2006-07-10 | 2007-07-10 | (3-aryl-piperazin-1-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| PCT/DK2007/000351 WO2008006372A1 (en) | 2006-07-10 | 2007-07-10 | (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2057153T3 true PL2057153T3 (pl) | 2013-01-31 |
Family
ID=40925377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07764480T PL2057153T3 (pl) | 2006-07-10 | 2007-07-10 | POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8492394B2 (pl) |
| EP (1) | EP2057153B1 (pl) |
| JP (1) | JP2009542732A (pl) |
| CN (1) | CN101495476A (pl) |
| CY (1) | CY1113314T1 (pl) |
| DK (1) | DK2057153T3 (pl) |
| ES (1) | ES2392553T3 (pl) |
| HR (1) | HRP20120835T1 (pl) |
| PL (1) | PL2057153T3 (pl) |
| PT (1) | PT2057153E (pl) |
| RS (1) | RS52562B (pl) |
| SI (1) | SI2057153T1 (pl) |
| WO (1) | WO2008006372A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI487705B (zh) * | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
| TWI485151B (zh) * | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TWI481607B (zh) * | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物 |
| WO2012018909A1 (en) * | 2010-08-04 | 2012-02-09 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| CN103476757A (zh) | 2011-02-18 | 2013-12-25 | 阿勒根公司 | 作为磷酸二酯酶10(pde10a)的抑制剂的取代的6,7-二烷氧基-3-异喹啉醇衍生物 |
| US9938269B2 (en) | 2011-06-30 | 2018-04-10 | Abbvie Inc. | Inhibitor compounds of phosphodiesterase type 10A |
| CN103874701A (zh) * | 2011-09-09 | 2014-06-18 | H.隆德贝克有限公司 | 吡啶化合物和其用途 |
| US20130116241A1 (en) | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
| CN104203919A (zh) | 2011-11-09 | 2014-12-10 | 艾伯维德国有限责任两合公司 | 可用作10a型磷酸二酯酶的抑制剂的杂环甲酰胺类 |
| UY34980A (es) | 2012-08-17 | 2014-03-31 | Abbvie Inc | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a |
| SG11201502074YA (en) | 2012-09-17 | 2015-05-28 | Abbvie Deutschland | Novel inhibitor compounds of phosphodiesterase type 10a |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| US9790203B2 (en) | 2012-11-26 | 2017-10-17 | Abbvie Inc. | Inhibitor compounds of phosphodiesterase type 10A |
| US9200005B2 (en) | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| MX2015012008A (es) | 2013-03-14 | 2016-04-15 | Abbvie Deutschland | Compuestos inhibidores novedosos de fosfodiesterasa tipo 10a. |
| WO2015006689A1 (en) | 2013-07-12 | 2015-01-15 | University Of South Alabama | Treatment and diagnosis of cancer and precancerous conditions using pde10a inhibitors and methods to measure pde10a expression |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| TW201611834A (en) * | 2014-02-07 | 2016-04-01 | Lundbeck & Co As H | Hexahydrofuropyrroles as PDE1 inhibitors |
| EP3807271A1 (en) * | 2018-06-13 | 2021-04-21 | F. Hoffmann-La Roche AG | Pyridinyl heterocyclyl compounds for the treatment of autoimmune disease |
| EP3856185A1 (en) | 2018-09-28 | 2021-08-04 | Takeda Pharmaceutical Company Limited | Balipodect for treating or preventing autism spectrum disorders |
| US20220267269A1 (en) * | 2019-06-14 | 2022-08-25 | Srx Cardio, Llc | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2556413A1 (en) * | 2004-02-18 | 2005-09-09 | Pfizer Products Inc. | Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| AU2005282721A1 (en) | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| BRPI0707223A2 (pt) * | 2006-01-27 | 2011-04-26 | Pfizer Prod Inc | compostos de derivados de aminoftalazina |
| US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| AU2007223801A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
-
2007
- 2007-07-10 US US12/306,021 patent/US8492394B2/en not_active Expired - Fee Related
- 2007-07-10 DK DK07764480.5T patent/DK2057153T3/da active
- 2007-07-10 SI SI200731052T patent/SI2057153T1/sl unknown
- 2007-07-10 PT PT07764480T patent/PT2057153E/pt unknown
- 2007-07-10 PL PL07764480T patent/PL2057153T3/pl unknown
- 2007-07-10 JP JP2009518719A patent/JP2009542732A/ja active Pending
- 2007-07-10 RS RS20120467A patent/RS52562B/sr unknown
- 2007-07-10 ES ES07764480T patent/ES2392553T3/es active Active
- 2007-07-10 HR HRP20120835TT patent/HRP20120835T1/hr unknown
- 2007-07-10 WO PCT/DK2007/000351 patent/WO2008006372A1/en not_active Ceased
- 2007-07-10 EP EP07764480A patent/EP2057153B1/en active Active
- 2007-07-10 CN CNA2007800261118A patent/CN101495476A/zh active Pending
-
2012
- 2012-10-17 CY CY20121100977T patent/CY1113314T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2057153E (pt) | 2012-11-14 |
| JP2009542732A (ja) | 2009-12-03 |
| WO2008006372A1 (en) | 2008-01-17 |
| EP2057153B1 (en) | 2012-09-12 |
| HRP20120835T1 (hr) | 2012-11-30 |
| DK2057153T3 (da) | 2012-10-15 |
| RS52562B (sr) | 2013-04-30 |
| CY1113314T1 (el) | 2016-04-13 |
| EP2057153A1 (en) | 2009-05-13 |
| US8492394B2 (en) | 2013-07-23 |
| SI2057153T1 (sl) | 2012-12-31 |
| US20110098286A1 (en) | 2011-04-28 |
| ES2392553T3 (es) | 2012-12-11 |
| CN101495476A (zh) | 2009-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2057153T1 (sl) | (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin | |
| IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
| ZA200709043B (en) | Benzodioxane and benzodioxalane derivatives and uses thereof | |
| SI1802579T1 (sl) | Derivati 3-arilaminopiridina | |
| IL198397A0 (en) | Anilinopiperazine derivatives and methods of use thereof | |
| ZA200810709B (en) | Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof | |
| IL198847A (en) | Process for making 2-imino-thiazolidine-4-on and several such histories | |
| EP1951680A4 (en) | NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE | |
| PT2084148E (pt) | Derivados carboximidamidas n-substituídos | |
| IL196671A0 (en) | Substituted imidazolone derivatives, preparation and uses | |
| EP1951215A4 (en) | HYDRAZONE DERIVATIVES AND ITS USES | |
| IL192427A0 (en) | Derivatives of sulindac, use thereof and preparation thereof | |
| IL198236A0 (en) | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof | |
| IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
| EP2025667A4 (en) | 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS | |
| EP2077262A4 (en) | IMINOPYRIDINE DERIVATIVE AND USE THEREOF | |
| PL2410047T3 (pl) | Oksydoreduktaza i jej zastosowanie do redukcji sekodionu | |
| EP1991233A4 (en) | Hydroxypiperidine derivatives and their use | |
| IL195430A0 (en) | Arylsulfonamidyl tetralin derivatives and uses thereof | |
| EP2068903A4 (en) | S-NITROSOTHIOL COMPOUNDS AND RELATED DERIVATIVES | |
| ZA200900960B (en) | Arylpiperazine derivatives and uses thereof | |
| IL198940A0 (en) | Stable s-nitrosothiols, method of synthesis and use | |
| GB0605295D0 (en) | Amino and derivatives | |
| IL194737A0 (en) | 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof | |
| IL196823A0 (en) | Tetraarylporphine derivatives and uses thereof |